ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677784 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677784; 2) Community: the network communities that were significantly associated with the response to NSC 677784; 3) Molecule: the relationships between components within communities and NSC 677784; 4) MDR: the compounds that were significantly associated with the NSC 677784.

NSC Compound Enrichment Correlation
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0297837393005856 0.17021079
NSC 135880 Null 0.0297837393005856 0.24529183
NSC 244404 Null 0.0297837393005856 0.41099659
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0297837393005856 0.047062425
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0297837393005856 0.36834213
NSC 313681 Oxiperomide(USAN) 0.0297837393005856 0.19546551
NSC 321240 Null 0.0297837393005856 0.26374987
NSC 328410 Camptothecin Derivative 0.0297837393005856 0.1780843
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0297837393005856 0.10749716
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.3302758
Total:70  Current:44    [First] [Prev] [Next] [Last]